{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:57:43Z","timestamp":1790989063769,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016305","name":"First Affiliated Hospital of Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["LHGJ20210291"],"award-info":[{"award-number":["LHGJ20210291"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168419","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:57:01Z","timestamp":1786805821000},"page":"168419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP53-ALKBH5 axis inhibition boosts m6A-modified TERT RNA degradation: A potential therapeutic strategy for glioblastoma"],"prefix":"10.1016","volume":"1873","author":[{"given":"Guihong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168419_bb0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2026.168419_bb0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","article-title":"Genetic and molecular epidemiology of adult diffuse glioma","volume":"15","author":"Molinaro","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2026.168419_bb0015","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1349-7006.2009.01308.x","article-title":"Genetic alterations and signaling pathways in the evolution of gliomas","volume":"100","author":"Ohgaki","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2026.168419_bb0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1083\/jcb.200412081","article-title":"Integrins control motile strategy through a Rho-cofilin pathway","volume":"169","author":"Danen","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168419_bb0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrn3765","article-title":"A neurocentric perspective on glioma invasion","volume":"15","author":"Cuddapah","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2026.168419_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biocel.2018.06.001","article-title":"Ubiquitination: friend and foe in cancer","volume":"101","author":"Mansour","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168419_bb0035","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","article-title":"A genomic and functional inventory of deubiquitinating enzymes","volume":"123","author":"Nijman","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168419_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101077","article-title":"Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response","volume":"297","author":"Snyder","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2026.168419_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41435-021-00125-9","article-title":"USP15: a review of its implication in immune and inflammatory processes and tumor progression","volume":"22","author":"Georges","year":"2021","journal-title":"Genes Immun."},{"key":"10.1016\/j.bbadis.2026.168419_bb0050","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.7150\/ijbs.91957","article-title":"Endothelial Dickkopf-1 promotes smooth muscle cell-derived foam cell formation via USP53-mediated deubiquitination of SR-A during atherosclerosis","volume":"20","author":"Liu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2026.168419_bb0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41419-021-03517-x","article-title":"Ubiquitin-specific protease 53 promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells","volume":"12","author":"Baek","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168419_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15205033","article-title":"USP53 exerts tumor-promoting effects in triple-negative breast cancer by deubiquitinating CRKL","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2026.168419_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41389-022-00404-8","article-title":"USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c","volume":"11","author":"Yao","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbadis.2026.168419_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/carcin\/bgab123","article-title":"USP53 activated by H3K27 acetylation regulates cell viability, apoptosis and metabolism in esophageal carcinoma via the AMPK signaling pathway","volume":"43","author":"Cheng","year":"2022","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2026.168419_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-biochem-052521-035330","article-title":"The proteins of mRNA modification: writers, readers, and erasers","volume":"92","author":"Flamand","year":"2023","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbadis.2026.168419_bb0080","article-title":"Pan-cancer analysis shows that ALKBH5 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including gliomas","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168419_bb0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/sj.onc.1205072","article-title":"Telomerase as a therapeutic target for malignant gliomas","volume":"21","author":"Komata","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168419_bb0090","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbrc.2015.11.046","article-title":"MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT","volume":"468","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2026.168419_bb0095","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-22-0800","article-title":"ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168419_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106863","article-title":"HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5","volume":"195","author":"Huo","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2026.168419_bb0105","first-page":"221","article-title":"In vivo glioblastoma tumor modeling via stereotaxic injection in mice for tumor progression studies","author":"Silva-Ag\u00fcero","year":"2025","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbadis.2026.168419_bb0110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.25709","article-title":"Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection","volume":"129","author":"Kroonen","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168419_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105202","article-title":"Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice","volume":"105","author":"Roncali","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbadis.2026.168419_bb0120","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1007\/s12035-022-02996-z","article-title":"Tumor microenvironment and immune escape in the time course of glioblastoma","volume":"59","author":"Virtuoso","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2026.168419_bb0125","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41419-018-1195-4","article-title":"Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM","volume":"9","author":"Przystal","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168419_bb0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/med.21421","article-title":"Targeting deubiquitinating enzymes in glioblastoma Multiforme: expectations and challenges","volume":"37","author":"Jin","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbadis.2026.168419_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv326","article-title":"ST3GAL1-associated transcriptomic program in glioblastoma tumor growth, invasion, and prognosis","volume":"108","author":"Chong","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbadis.2026.168419_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2026.168419_bb0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2022.11.025","article-title":"PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment","volume":"353","author":"Yang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbadis.2026.168419_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-022-01224-4","article-title":"RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential","volume":"15","author":"Qu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168419_bb0155","article-title":"USP53 drives ethanol-induced myocardial injury by promoting K63 deubiquitination-dependent RIPK1 activation at K377","volume":"8","author":"Pan","year":"2025","journal-title":"Research (Washington, DC)."},{"key":"10.1016\/j.bbadis.2026.168419_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2026.168419_bb0165","article-title":"Ubiquitin-specific proteases: players in cancer cellular processes","volume":"14","author":"Cruz","year":"2021","journal-title":"Pharmaceuticals (Basel, Switzerland)."},{"key":"10.1016\/j.bbadis.2026.168419_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139910","article-title":"Protein molecular structures of USP53, NPY2R, and DCTN1-AS1 and impact on tumors: analysis of prognostic biomarkers for diffuse large B-cell lymphoma","volume":"297","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2026.168419_bb0175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/onc.2012.66","article-title":"The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer","volume":"32","author":"Li","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168419_bb0180","article-title":"USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis","volume":"1870","author":"Gao","year":"2024","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2026.168419_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2023.10.025","article-title":"EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma","volume":"83","author":"Lv","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2026.168419_bb0190","article-title":"TDP-43\/ALKBH5-mediated m(6)a modification of CDC25A mRNA promotes glioblastoma growth by facilitating G1\/S cell cycle transition","volume":"6","author":"Zhang","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.bbadis.2026.168419_bb0195","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/neuonc\/noac238","article-title":"USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5","volume":"25","author":"Chang","year":"2023","journal-title":"Neuro-oncology."},{"key":"10.1016\/j.bbadis.2026.168419_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.09.014","article-title":"Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2","volume":"36","author":"Lv","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2026.168419_bb0205","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1158\/1535-7163.MCT-09-0097","article-title":"Small-molecule inhibitor of USP7\/HAUSP ubiquitin protease stabilizes and activates p53 in cells","volume":"8","author":"Colland","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2026.168419_bb0210","first-page":"39","article-title":"USP2 reversed cisplatin resistance through p53-mediated ferroptosis in NSCLC","volume":"18","author":"Gong","year":"2025","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.bbadis.2026.168419_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1593\/neo.07929","article-title":"FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway","volume":"10","author":"Jiang","year":"2008","journal-title":"Neoplasia (New York, NY)."},{"key":"10.1016\/j.bbadis.2026.168419_bb0220","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41416-019-0413-x","article-title":"High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme","volume":"120","author":"Kamil","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168419_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00170","article-title":"Lcn2-derived circular RNA (hsa_circ_0088732) inhibits cell apoptosis and promotes EMT in glioma via the miR-661\/RAB3D axis","volume":"10","author":"Jin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2026.168419_bb0230","doi-asserted-by":"crossref","first-page":"D303","DOI":"10.1093\/nar\/gkx1030","article-title":"MODOMICS: a database of RNA modification pathways. 2017 update","volume":"46","author":"Boccaletto","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2026.168419_bb0235","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbadis.2026.168419_bb0240","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00018-016-2146-9","article-title":"Reactivation of telomerase in cancer","volume":"73","author":"Akincilar","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2026.168419_bb0245","article-title":"Treating cancer by targeting telomeres and telomerase","volume":"6","author":"Ivancich","year":"2017","journal-title":"Antioxidants (Basel, Switzerland)."},{"key":"10.1016\/j.bbadis.2026.168419_bb0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbadis.2026.168419_bb0255","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.drudis.2020.04.024","article-title":"In silico design of telomerase inhibitors","volume":"25","author":"Baginski","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbadis.2026.168419_bb0260","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejmech.2017.12.077","article-title":"Inhibitor of the human telomerase reverse trancriptase (hTERT) gene promoter induces cell apoptosis via a mitochondrial-dependent pathway","volume":"145","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbadis.2026.168419_bb0265","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/neuonc\/noac112","article-title":"Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma","volume":"24","author":"Minami","year":"2022","journal-title":"Neuro-oncology."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:25:49Z","timestamp":1790987149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926002826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926002826"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168419","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP53-ALKBH5 axis inhibition boosts m6A-modified TERT RNA degradation: A potential therapeutic strategy for glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168419"}}